Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Aerosolized Pentamidine vs TMP-SMX for PCP in AIDS
NCT00002056Phase 3Completed
- Sponsor
- LyphoMed Inc.
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of pentamidine in Pneumocystis jirovecii pneumonia (PJP) (2 arms), sponsored by LyphoMed Inc. Primary endpoint: Survival during study Days 1 to 35 at 35 days. Status: completed.
02
Drugs
pentamidine
03
Conditions
Pneumocystis jirovecii pneumonia (PJP)
Beyond the preview
Go deeper on NCT00002056.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00002056.